Relationship of proinsulin and insulin to cardiovascular risk factors in nondiabetic subjects. 
Recent data suggest that proinsulin is strongly associated with cardiovascular risk factors in diabetic subjects.  However, this relationship has not been examined in nondiabetic subjects.  Therefore, we examined the relation of proinsulin to lipids, obesity (body mass index), and waist-to-hip ratio in 260 nondiabetic individuals from the San Antonio Heart Study, a population-based study of diabetes and cardiovascular disease.  Proinsulin was measured by radioimmunoassay, and insulin was measured by a Linco radioimmunoassay that does not cross-react with proinsulin.  Fasting insulin was significantly associated with body mass index (0.42), waist-to-hip ratio (r = 0.30), triglyceride (r = 0.29), high-density lipoprotein cholesterol (r = -0.20), and systolic blood pressure (r = 0.16) but not significantly related to diastolic blood pressure (r = 0.11).  Fasting proinsulin was significantly associated with body mass index (r = 0.19), waist-to-hip ratio (r = 0.25), triglyceride (r = 0.41), systolic blood pressure (r = 0.19), and diastolic blood pressure (r = 0.15).  Proinsulin was more strongly related to increased triglyceride than insulin despite its weaker relationship to obesity.  In multivariate analyses, proinsulin continued to be significantly related to triglyceride concentrations (explaining 23.1% of the variance) and to systolic blood pressure (explaining 4.0% of the variance), even after adjusting for insulin.  These observations suggest that proinsulin should be measured in addition to insulin in epidemiological studies.  Proinsulin may be a marker for metabolic decompensation in prediabetic subjects.